Pickering Grant's Form 4/A amendment
AmendedVaxcyte, Inc. (PCVX) · filed Sep 30, 2022
- Accession no.
- 0001209191-22-051682
- Filed
- Sep 30, 2022
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 28, 2022
This filing lists no transactions. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $247.2K.
This amendment restates part of 0001209191-22-051492 (filed Sep 28, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pickering GrantCIK 0001258693 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-22-051492 (filed Sep 28, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2022 | Common Stock | SSaleDisposed | −4,773 | $24.69F2 | −$117,845.37 | 158,057 | Indirect | |
| Sep 26, 2022 | Common Stock | SSaleDisposed | −227 | $25.30F4 | −$5,743.1 | 157,830 | Indirect | |
| Sep 26, 2022 | Common Stock | SSaleDisposed | −4,681 | $24.68F5 | −$115,527.08 | 158,149 | Indirect | |
| Sep 26, 2022 | Common Stock | SSaleDisposed | −319 | $25.28F7 | −$8,064.32 | 157,830 | Indirect |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
The price reported is a weighted-average price. The shares were sold at prices ranging from $24.215 to $25.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted-average price. The shares were sold at prices ranging from $25.26 to $25.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted-average price. The shares were sold at prices ranging from $24.23 to $25.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported is a weighted-average price. The shares were sold at prices ranging from $25.25 to $25.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On September 22, 2022, the Reporting Person entered into a divorce settlement agreement with his ex-spouse (the "Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Since the date of the Reporting Person's ownership report filed on September 19, 2022 (the "Prior Ownership Report"), the Reporting Person effectively transferred 293,228 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Of these 293,228 shares, Reporting Person has transferred the economic interest in 28,632 shares. While the Reporting Person will retain these shares, the Reporting Person's ex-spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the shares representing the spouse's transferred economic interest, including any sales of shares underlying such portion. Continued in footnote 2.
- F2
Continued from footnote 1. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares or the portion of such shares representing his ex-spouse's transferred economic interest, nor will the Reporting Person report beneficial ownership of or acquisitions or dispositions of the shares, in future Section 16(a) filings.
- F3
The shares subject to the option representing the Reporting Person's remaining economic interest are fully vested and exercisable.
- F4
Since the date of the Prior Ownership Report, Reporting Person transferred 13,663 stock options to Reporting Person's ex-spouse pursuant to the Settlement Agreement. The Reporting Person will no longer report beneficial ownership of these stock options, or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.
- F5
Since the date of the Prior Ownership Report, Reporting Person transferred 117,225 stock options to Reporting Person's ex-spouse pursuant to the Settlement Agreement. The Reporting Person will no longer report beneficial ownership of these stock options, or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.
- F6
Since the date of the Prior Ownership Report, Reporting Person effectively transferred 276,947 stock options to Reporting Person's ex-spouse pursuant to the Settlement Agreement. Of these 276,947 stock options, Reporting Person has transferred the economic interest in 91,457 stock options, all of which he will currently hold in constructive trust. While the Reporting Person will retain these stock options, the Reporting Person's ex-spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the stock options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Continued in footnote 7.
- F7
Continued from footnote 6. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed stock options or the portion of such stock options representing his ex-spouse's transferred economic interest, nor will the Reporting Person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.
- F8
As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments from October 20, 2022 to March 20, 2024.
- F9
Since the date of the Prior Ownership Report, Reporting Person effectively transferred 108,840 stock options to Reporting Person's ex-spouse pursuant to the Settlement Agreement. Of these 108,840 stock options, Reporting Person has transferred the economic interest in 21,241 stock options, all of which he will currently hold in constructive trust. While the Reporting Person will retain these stock options, the Reporting Person's ex-spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the stock options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Continued in footnote 10.
- F10
Continued from footnote 9. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed stock options or the portion of such stock options representing his ex-spouse's transferred economic interest, nor will the Reporting Person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.
- F11
As of the date of transfer, the shares subject to the option representing the Reporting Person's remaining economic interest will vest in monthly installments from October 1, 2022 to April 1, 2025.
- F12
Since the date of the Prior Ownership Report, Reporting Person effectively transferred 6,888 stock options to Reporting Person's ex-spouse pursuant to the Settlement Agreement. Of these 6,888 stock options, Reporting Person has transferred the economic interest in 1,575 stock options, all of which he will currently hold in constructive trust. While the Reporting Person will retain these stock options, the Reporting Person's ex-spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the stock options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Continued in footnote 13.
- F13
Continued from footnote 12. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed stock options or the portion of such stock options representing his ex-spouse's transferred economic interest, nor will the Reporting Person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.
Remarks
This amendment to Form 4 is being filed solely to report exempt transfers pursuant to a domestic relations order that were not reported in the original Form 4 filing as final numbers were not yet available at the time of filing.